Clinical Trial Update: Evaluation of the Tolerance of Afatinib in Combination With Docetaxel and Cisplatin in LAHNSCC Induction Chemotherapy [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates tolerability/safety of adding afatinib to docetaxel and cisplatin as induction chemotherapy for locally advanced head and neck squa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Afatinib (afatinib)
• CISPLATIN (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: HNSCC | Phase 1 | Status: COMPLETED